









Markets
/
Stocks
/
nasdaq-smti
/

Sanara Medtech Inc

SMTI

View Detailed Chart

24.760USD

+0.600+2.48%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

220.45MMarket Cap

LossP/E TTM



Sanara Medtech Inc

24.760

+0.600+2.48%

Overview Company Financials

Financials

Intraday

30m

Today

+2.48%

5 Days

-3.02%

1 Month

-16.49%

6 Months

-30.39%

Year to Date

-25.42%

1 Year

-13.73%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

49.000

Target Price

102.81%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Sanara Medtech Inc

SMTI

Biogen Inc

BIIB

Alnylam Pharmaceuticals Inc

ALNY

Vertex Pharmaceuticals Inc

VRTX

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(0)

Buy(1)

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.553

Sell

RSI(14)

29.766

Sell

STOCH(KDJ)(9,3,3)

9.901

Oversold

ATR(14)

1.302

Low Volatility

CCI(14)

-145.749

Sell

Williams %R

88.810

Oversold

TRIX(12,20)

-0.605

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

24.694

Buy

MA10

25.469

Sell

MA20

27.094

Sell

MA50

28.256

Sell

MA100

29.742

Sell

MA200

32.110

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

Ticker SymbolSMTI

CompanySanara Medtech Inc

CEOMr. Suresh V. (Sam) Muppalla

Websitehttps://sanaramedtech.com/